During the past decade, Yale Center for Clinical Investigation conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 13 clinical trials were completed, i.e. on average, 81.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yale Center for Clinical Investigation" #1 sponsor was "Yale University" with 20 trials, followed by "BioNTech SE" with 2 trials sponsored, "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "Patagonia Pharmaceuticals, LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale Center for Clinical Investigation" #1 collaborator was "National Institute on Alcohol Abuse and Alcoholism (NIAAA)" with 5 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 4 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator and "American Heart Association" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Yale Center for Clinical Investigation" are "Smoking" (4 trials), "Congenital Ichthyosis" (2 trials), "Granuloma Annulare" (2 trials), "AIDS" (1 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "Yale Center for Clinical Investigation" in a lesser frequency.

Most popular intervention types in "Yale Center for Clinical Investigation" are "Drug" (19 trials), "Behavioral" (4 trials), "Other" (4 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Guanfacine" (2 trials), "placebo" (2 trials), "varenicline" (2 trials) and "AC-1101" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale Center for Clinical Investigation" are 27 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Yale Center for Clinical Investigation". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Yale Center for Clinical Investigation, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Yale Center for Clinical Investigation, 6 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".